X

Perspective from Sites who have Embraced a New World (or Decentralized) Approach

Katherine Vandebelt
Global Head of Clinical Innovation

There is much talk about the ever-increasing role of patient-facing technologies in clinical trials, however, as the industry progresses in the ‘early adoption stage’ into ‘early majority’, many organizations struggle with the preparation for these new protocol components and possible extended team members.

Let’s begin with what is defined and what still needs to be sorted with this new virtual ecosystem, as we are always learning. What exactly do terms like remote, site-less, hybrid, and decentralized trials mean and do for us? In order to work together, we need to better understand each other and what terms help and hinder our progress.

Whatever the term may be, early planning and implementation stages to protect the integrity of the data will be key to success. Adaption, compliance and regulatory acceptance plays a large role in the development and use of new innovation in clinical trials as well. Above all, it is crucial to protect the safety of the patient.

In collaboration with CNS Summit, Oracle Health Sciences recently met with industry stakeholders to understand the value realized from the decentralized trial approach. In a focus group setting, participants pooled their experience and knowledge to examine the benefits, the challenges and the pace of adoption of various decentralized approaches.

Please join us for the upcoming webcast “Virtual, Decentralized, Site-less Trials… What Does it All Mean?”, where I will join Dr. Vishaal Mehra, CEO & Medical Director, Artemis, to explore and discuss the aspects of this new frontier to gain full knowledge of its potential, and what the future holds for all of us involved.

We will gain a deeper understanding from the site view on what is involved in preparing for these types of trials, adapting roles to fulfill responsibilities and the value it offers those who engage. Practical advice will be shared based on experience and motivation to see virtual components applied effectively to clinical research.

Please join us for this webcast:

Live: Thursday, March 12, 2020

11am EDT | 10am CDT | 8am PDT

On Demand: available after airing until March 12, 2021

This webcast is the second in a three-part series focusing on the journey organizations must take to move towards decentralized trials, or hybrid trials. The series will explore this new realm of virtual and tackle questions such as ‘why’ the change is necessary, and ‘how’ to change. Each webcast will provide clear instruction on how to move towards a virtual ecosystem that is right for your organization.

Watch the recording of part one in this webcast series Three Key Critical Considerations Before Embarking on Decentralized Trials

Be the first to comment

Comments ( 0 )
Please enter your name.Please provide a valid email address.Please enter a comment.CAPTCHA challenge response provided was incorrect. Please try again.